Simpson-Golabi-Behmel Syndrome – Definition

Simpson-Golabi-Behmel syndrome (SGBS, OMIM #312870) is an X-linked macrosomia syndrome associated with malformations, reduced intelligence, and an increased risk of developing tumors.

Synonym:

Genes:

GPC3 and GPC4 (not all genes known yet)

Gene ­products:

Glypican-3 (GPC3) and Glypican-4 (GPC4)

Function:

GPC3 and GPC4 are cell-surface-bound proteoglycans

Pattern of inheritance:

X-chromosomal

Prevalence:

Rare

Genotype-phenotype correlation:

Involved are loss-of-function mutations without a known correlation.

Penetrance:

Presumably complete in male carriers of the pathogenic variant. Rarely, female carriers of the pathogenic variant may also be affected.

Overview of the Chapters on This Page:

  • Clinical Presentation

  • Special Features of Treatment

  • Recommendations for Early Detection in Your Patients
  • Further Information (e.g., Links to Support Groups)

  • Clinical Presentation

  • Special Features of Treatment

  • Recommendations for Early Detection in Your Patients
  • Further Information (e.g., Links to Support Groups)

Simpson-Golabi-Behmel Syndrome – Diagnosis

Diagnosis

The diagnosis is made clinically and can be confirmed with an analysis of the pathogenic variant in patients with a defect in a known gene. Not all SGBS genes are known, so genetic confirmation is not always possible.

Differential Diagnoses

Clinical Presentation

SGBS is characterized by pre- and postnatal macrosomia, typical craniofacial changes (with macrocephaly, coarse facial features, macrostomia, macroglossia, palatal anomalies), and often mild to severe intellectual impairment with or without structural brain changes. Other variable characteristics include a supernumerary nipple, rectus diastasis/umbilical hernia, diaphragmatic hernia, congenital heart defects, urogenital malformations, and gastrointestinal (GI) anomalies. Skeletal anomalies (vertebral fusion, scoliosis, rib anomalies, hip dysplasia) and hand anomalies (large hands and post-axial polydactyly) may also be present.

The following tumors have been described in patients with SGBS: Wilms tumors and nephroblastomatosis, liver tumors, and neuroblastoma. One child with SGBS and medulloblastoma was described.

Special Features of Treatment

Complex, multi-professional. There are no known special features for cancer treatment.

Diagnosis of Simpson-Golabi-Behmel Syndrome- What's Next?

Once diagnosed, it is recommended that a cancer predisposition specialist manage the patient. The following section explains whether cancer screening tests or other measures are necessary and how they should be performed. Some additional information, including links to support groups, is also included at the end of this page.

Diagnosis of Simpson-Golabi-Behmel Syndrome - What's Next?

Once diagnosed, it is recommended that a cancer predisposition specialist manage the patient. The following section explains whether cancer screening tests or other measures are necessary and how they should be performed. Some additional information, including links to support groups, is also included at the end of this page.

Recommendations for Early Detection in Your Patients

According to the latest AACR guidelines, the following screening tests are recommended for patients with Simpson-Golabi-Behmel syndrome:

  • Physical examination every 6 months
  • Wilms’ tumour: Sonography of the kidneys every 3 months from birth to 7 years of age
  • Hepatoblastoma: Abdominal ultrasound + AFP measurement every 3 months from birth until the age of 3 years

Simpson-Golabi-Behmel Syndrome- Further Information

Open Clinical Trials/ Registers

Additional Resources and Links

Unfortunately, we are currently not aware of any support groups for patients with Simpson-Golabi-Behmel syndrome. New information will be added as soon as it becomes available.

Sources
  • Jennifer M. Kalish, Kerri D. Becktell, Gaëlle Bougeard, Garrett M. Brodeur, Lisa R. Diller, Andrea S. Doria, Jordan R. Hansford, Steven D. Klein, Wendy K. Kohlmann, Christian P. Kratz, Suzanne P. MacFarland, Kristian W. Pajtler, Surya P. Rednam, Jaclyn Schienda, Lisa J. States, Anita Villani, Rosanna Weksberg, Kristin Zelley, Gail E. Tomlinson, Jack J. Brzezinski; Update on Surveillance for Wilms Tumor and Hepatoblastoma in Beckwith–Wiedemann Syndrome and Other Predisposition Syndromes. Clin Cancer Res 1 December 2024; 30 (23): 5260–5269. https://doi.org/10.1158/1078-0432.CCR-24-2100